Peer Reviewed Journal
2024, Vol. 4, Issue 1, Part A
Design, synthesis, and pharmacological profiling of piperazine-based CNS stimulants for ADHD treatment
Author(s): Michael Schick
Abstract: Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. Current treatments include stimulant medications, which can have significant side effects and potential for abuse. This study aims to design and synthesize novel piperazine-based CNS stimulants with improved efficacy and safety profiles for the treatment of ADHD. Using computational modeling, chemical synthesis, and pharmacological profiling, we identify several piperazine derivatives with promising stimulant activity and favorable pharmacokinetic properties. These findings offer a potential new avenue for ADHD treatment.
Pages: 48-50 | Views: 481 | Downloads: 189
Download Full Article: Click Here
How to cite this article:
Michael Schick. Design, synthesis, and pharmacological profiling of piperazine-based CNS stimulants for ADHD treatment. Nat J Pharm Sci 2024;4(1):48-50.
